Incorporating the 40-gene expression profile (40-GEP) test for poorly differentiated cutaneous squamous cell carcinoma (cSCC) tumors mitigates risk assessment uncertainty from histologic grading

Main Article Content

Aaron Farberg
Jennifer Siegel
Sarah Kurley
Alison Fitzgerald
Anesh Prasai
Matthew Goldberg
Sherrif Ibrahim
Sarah Estrada


risk assessment, cSCC, differentiation status, gene expression profile


1., 2022

2. Schmults, et al. JAMA Derm 2013

3. NCCN v2.2022

4. Thompson, et al. JAMA Derm 2016

5. Karia, et al. JCO 2014

6. Wysong, et al. JAAD 2021

7. Ibrahim, et al. Future Onc. 2021

8. Patel, et al. Cancer Medicine 2022

9. Jagdeo, et al. JAAD 2007

10. Prezzano, et al. Derm Surg 2021

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 > >>